Article Detail

Home > Article Detail
  • P-ISSN 1010-0695
  • E-ISSN 2288-3339

A Study on Using EAV (MERIDIAN) by Analysis of Cerebrovascular Disease Risk Factors

Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2010, v.31 no.5, pp.136-145






  • Downloaded
  • Viewed

Abstract

Objectives: Electroacupuncture according to Voll (EAV) has been used to quantify the skin's electrical resistance and conductance over acupuncture points that, based on traditional Chinese medicine, represent the state of health or disease of the organ or tissue. However, it doesn't have enough objective data yet, so the purpose of this study was to aid in the use of EAV in analysis of cerebrovascular disease risk factors. Methods: This study researched the clinical statistics of 216 cases: cerebrovascular attack (CVA) group 43, control group 173. We measured control meridian points (CMP) on hands and feet and the cardio ankle vascular index (CAVI) which represents atherosclerosis severity, and sex, age, hypertension, diabetes, dyslipidemia, and obesity. The data were then analyzed by t-test, chi-square test and logistic regression. Results: Between the CVA and control groups, there were not statistically significant differences in CMP. However, logistic regression analysis of the presence of CVA, mean of CMP heart and lung, sex, age, DBP (diastolic blood pressure), and HDL (high density lipoprotein) cholesterol showed that the risk of CVA was 1.1 times increased with CMP heart (p=0.002), in men was 4.12 times higher than in women (p=0.001), 1.09 times higher with age (p=0.000), 1.04 times higher with DBP (p=0.045), while was lower by 0.924 times with CMP lung (p=0.005) and 0.957 times with HDL cholesterol (p=0.006). Conclusion: Although there were not clear evidence or mechanisms about EAV, this study showed that if we study EAV further, we may be able to apply EAV as an objective instrument of oriental medicine in cerebrovascular disease

keywords
Electroacupuncture, cerebrovascular disease.


Reference

1

1 통계청. 2008년 사망원인 통계원보. 2009년 국제통계연감. 2009.

2

2 Adams HP Jr, Bendixen BH, Kapplelle LJ, Biller J, Love BB, Gordon DL et al. Classification of subtypes of acute ischemic stroke. Definition for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute stroke Treatment. Stroke. 1993;24(1):35-41.

3

3 대한신경외과학회. 신경외과학. 2판. 서울: 대한신경외과학회. 2001:323.

4

4 Mohr JP, Choi DW, Grotta JC, Weir B, Wolf PA. Stroke: pathophysiology, diagnosis and management. 4th edition. Philadelphia: Churchill Livingstone. 2004:9-12.

5

5 Bogousslavsky J , Van Melle G, Regli F. The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke. 1988;19:1083-92.

6

6 Kobayashi S. Data bank project for acute stroke patients. Rinsho Shinkeigaku. 2002;42:1176-78.

7

7 Thrif AG, Dewey HM, Macdonel RAl, McNeil JJ, Donnan GA. Incidence of the major stroke subtypes: initial findings from the North East Melbourne stroke incidence study (NEMESIS). Stroke. 2001;32:1732-38.

8

8 Piecuch T, Jaworski R: Resting ankle-arm pressure index in vascular diseases of lower extremities. Angiology. 1989;40:181-5.

9

9 Ryu KJ, Kim JH. Study on Comarison of EAV measurement points with acupuncture points. Department of clinical research, KIOM. 1995;1 (1):363-400.

10

10 Shin YC, An SW. A study of the relations between meridian and the disease. Department of clinical research, KIOM. 1995;1(1):245-72.

11

11 허준, 신용철. 중풍환자의 EAV 측정치에 관한 연 구. 한국한의학연구원 논문집. 1995;1(1):151-67.

12

12 Han JS, Song IB. A study on the correlativity in EAV(Electroacupunture According to Voll)'s measurement and symptoms of a disease. J. of. Const. Med. 1995;7(1):43-67.

13

13 Royal FF, Royal DD. A review of the history and scientific bases of electrodiagnosis and its relationship to homeopathy and acupuncture. Am J Acupuncture. 1991;19(2):137-52.

14

14 한국한의학연구소 임상연구부. Voll 전침입문 : 전침요법 입문서. 1판. 서울: 한국한의학연구소. 1995:162-78.

15

15 Reinhold Voll. Twenty Years of Electroacupuncture Diagnosis in Germany. American Journal of Acupuncture. 1975;3(19):7-17.

16

16 (주)메리디안. MERIDIAN. 1판. 서울: (주)메리디안. 1997:1-138.

17

17 Yoon YC, Chang KS, Na CS, Cho JH. Analysis of physiological signal data measured in CVA patient. Journal of Oriental Physiology. 1997;12 (2):76-102.

18

18 전국 한의과대학 심계내과학 교실. 심계내과학.1판. 서울: 군자출판사. 2008:331-8.

19

19 Wolf PA, D'Agostino RB, O'Neal MA, Sytkowski P, Kase CS, Belanger AJ et al. Secular trends in stroke incidence and mortality. The Framingham Study. Stroke. 1992;23:1551-5.

20

20 질병관리본부 한국보건사회연구원. 국민건강영 양조사 제3기 조사결과 심층분석연구: 건강면접 및 보건의식 부문. 제1판. 서울: 질병관리본부. 2007:98-104.

21

21 MacMahon S, Peto R, Collins R, Godwin J, Cutler J, Cutler J et al. Blood pressure, stroke, and coronary heart disease : I. Prolonged differences in blood pressure : Prospective observational studies corrected for the regession dilution bias. Lancet. 1990;335:765.

22

22 Cameron JD, Jennings GL, Dart AM. The relationship between arterial compliance, age, blood pressure and serum lipid levels. Hypertension. 1995;13:1718-23.

23

23 Avolio AP, Chen S, Wang R, Zhang C, Li M, O'Rourke MF. Effects of aging in changing arterial compliance and left ventricular load in a northern chinese urban community. Circulation. 1983;68:50-8.

24

24 Nichols WW, O'rourke MF. Properties of the arterial wall. Mcdonald's blood flow in arteries : Theoretical, experimental and clinical principles. 3rd edition. London: Edward Arnold. 1990: 77-114.

25

25 Lehman ED, Gosling RG, Sonksen PH. Arterial wall compliance in diabetes. Diabet Med. 1992;9:114-9.

26

26 Wada T, Kodaira K, Fujishiro K, Maie K, Tsukiyama E, Fukumoto T et al. Correlation of ultrasound measured common carotid artery stiffness with pathological 26 findings. Arterioscler Thromb Casc Biol. 1994;14:479-82

27

27 London GM, Marchais SJ, Safar ME, Genest AF, Guerin AP, Metivier F et al. Aortic and large artery compliance in end stage renal failure.Kidney int. 1990;37:137-42.

28

28 Learoyd BM, Taylor MG. Alterations with age in the viscoelastic properties of human arterial wall. Circ es. 1996;18:278-92.

29

29 Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD et al. Primary prevention of ischemic stroke: A guideline from the American Heart Association. American Stroke Association Stroke. 2006;152:27-38.

30

30 Iso H, Jacobs D, Wentworth D, Neaton J, Cohen J. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989;320:904-10.

31

31 Amarenco P, Labreuche J, Lavallee P, Touboul P-J. Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to- Date Meta-Analysis. Stroke. 2004;35:2902-9.

32

32 Koren-Morag N, Tanne D, Graff E, Goldbourt U. Low and high density lipoprotein cholesterol and ischemic cerebrovascular disease. Archive of internal medicine. 2002;162:993-9.

33

33 Song YM, Sung J, Davey Smith G, Ebrahim S. Body mass index and ischemic and hemorrhagic stroke: a prospective study in Korean men. Stroke. 2004;35:831-6.

34

34 Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42:878-84.

상단으로 이동

Journal of Korean Medicine